Market icon

Завершит ли РФК одобрение вакцин к 31 декабря?

Market icon

Завершит ли РФК одобрение вакцин к 31 декабря?

Да

<1% chance
Polymarket

$7,093 Объем

Да

<1% chance
Polymarket

$7,093 Объем

This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."

The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Объем
$7,093
Дата окончания
Dec 31, 2025
Открытие рынка
Sep 3, 2025, 11:16 PM ET
This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution." The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

Предложенный исход: Нет

Спор отсутствует

Окончательный исход: Нет

This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."

The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Объем
$7,093
Дата окончания
Dec 31, 2025
Открытие рынка
Sep 3, 2025, 11:16 PM ET
This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution." The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

Предложенный исход: Нет

Спор отсутствует

Окончательный исход: Нет

Не доверяй внешним ссылкам.

Frequently Asked Questions

"Завершит ли РФК одобрение вакцин к 31 декабря?" is a prediction market on Polymarket with 2 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "Закончит ли RFK одобрение каких-либо вакцин до 31 декабря?" at 0%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 0¢ implies that the market collectively assigns a 0% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

"Завершит ли РФК одобрение вакцин к 31 декабря?" is a newly created market on Polymarket, launched on Sep 4, 2025. As an early market, this is your opportunity to be among the first traders to set the odds and establish the market's initial price signals. You can also bookmark this page to track volume and trading activity as the market gains traction over time.

To trade on "Завершит ли РФК одобрение вакцин к 31 декабря?," browse the 2 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

This is a wide-open market. The current leader for "Завершит ли РФК одобрение вакцин к 31 декабря?" is "Закончит ли RFK одобрение каких-либо вакцин до 31 декабря?" at just 0%. With no outcome commanding a strong majority, traders see this as highly uncertain, which can present unique trading opportunities. These odds update in real-time, so bookmark this page to watch how the probabilities evolve.

The resolution rules for "Завершит ли РФК одобрение вакцин к 31 декабря?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.